A Two-Period Study to Evaluate the Effects of Multiple Oral Doses of Itraconazole on the Single Dose PK of MK-1708 in Healthy Participants
Latest Information Update: 18 Nov 2024
Price :
$35 *
At a glance
- Drugs MK 1708 (Primary) ; Itraconazole
- Indications Alzheimer's disease; Amyotrophic lateral sclerosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 13 Nov 2024 Status changed from recruiting to active, no longer recruiting.
- 16 Oct 2024 Planned End Date changed from 18 Dec 2024 to 10 Dec 2024.
- 16 Oct 2024 Planned primary completion date changed from 18 Dec 2024 to 10 Dec 2024.